Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00453713 · ClinicalTrials.gov registry record
Race, Ethnicity, and Diffuse Parenchymal Lung Disease
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 565
- Enrollment target
NCT00453713: Completed study, sponsored by Columbia University.
NCT00453713 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 565 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00453713 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 565 participants
- Enrollment target
Study Summary
The purpose of this study is to identify factors that contribute to higher mortality rates among blacks and Hispanics with diffuse parenchymal lung disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 565 participants |
| Start Date | 2006-07 |
| Est. Completion | 2013-08 |
What the finished NCT00453713 record still lists
NCT00453713 is an observational study that tracks outcomes without assigning an intervention. The registered 565 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00453713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00453713 about?
NCT00453713 is a clinical study titled "Race, Ethnicity, and Diffuse Parenchymal Lung Disease". The purpose of this study is to identify factors that contribute to higher mortality rates among blacks and Hispanics with diffuse parenchymal lung disease.
What is the current status of trial NCT00453713?
This trial is currently completed. The enrollment target is 565 participants. The study started on 2006-07. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT00453713?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146725 · 564 participants
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
- NCT06188520 · 564 participants · Phase 1
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
- NCT06628453 · 564 participants · NA
CGM for Management of Type 2 Diabetes in Pregnancy
- NCT07125326 · 564 participants · NA
How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia